Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

Respondents broadly supported clearer guidance on how evidence on health inequalities should be presented and how impacts are ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...